Research Article

Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

Table 1

Baseline characteristics of T2DM cohort.

Total (n = 236)Below-median HE4 (n = 118)Above-median HE4 (n = 118) value

Age (y)61.6 ± 14.355.1 ± 11.968.0 ± 13.7<0.001
Female, n113 (48%)59 (50%)54 (46%)0.515
BMI23.8 ± 2.824.0 ± 2.923.6 ± 2.80.284
Current smoker, n38 (16%)18 (15%)20 (17%)0.859
Current drinker, n32 (14%)12 (10%)20 (17%)0.105
Hypertension, n115 (49)43 (36%)72 (61%)<0.001
Coronary heart disease14 (6)7 (6)7 (6)0.783
Peripheral neuropathy143 (61%)61 (52%)82 (69%)0.008
Peripheral artery disease67 (28%)24 (20%)43 (36%)0.009
Diabetic retinopathy26 (11%)11 (9%)15 (13%)0.533
Diabetic foot ulcers16 (7%)5 (4%)11 (9%)0.120
Diabetic ketosis26 (11%)15 (12%)11 (9%)0.533
DKD63 (53%)4 (5%)59 (50%)<0.001
Laboratory measurements
 eGFR94.9 (66.1–115.6)106.7 (95.0–128.4)66.8 (45.1–94.7)<0.001
 Blood glucose8.9 (6.3–12.9)9.3 (6.8–13.2)8.2 (5.8–12.1)0.134
 HbA1c9.3 (7.8–11.2)9.4 (7.6–11.2)9.1 (7.9–11.3)1.000
 Insulin9.5 (5.4–14.6)9.3 (5.3–13.6)10.4 (6.1–15.3)0.287
 C-peptide1.9 (0.9–2.7)1.8 (0.7–2.5)2.1 (1.2–3.1)0.007
 TG1.5 (1.1–2.3)1.6 (1.1–2.5)1.5 (1.2–2.1)0.406
 TC4.4 (3.7–5.3)4.7 (3.9–5.6)4.2 (3.6–5.3)0.029
 HDL-C1.1 (0.9–1.3)1.1 (0.9–1.4)1.0 (0.9–1.2)0.007
 LDL-C2.4 (1.8–3.1)2.6 (1.9–3.2)2.2 (1.7–3.0)0.037
 CRP3.2 (1.4–11.7)1.9 (1.1–4.6)5.6 (2.3–22.6)<0.001
 Urea5.5 (4.4–7.5)4.9 (4.2–5.7)7.2 (5.3–10.6)<0.001
 Creatinine66.0 (55.0–89.8)58.0 (50.0–70.0)83.5 (62.0–125.3)<0.001
 UA312.0 (251.0–391.0)282.0 (233.0–342.0)360.0 (275.5–439.5)<0.001

T2DM, type 2 diabetes mellitus; HE4, human epididymis protein 4; BMI, body mass index; DKD, diabetic kidney disease; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; TG, triglyceridecreatinine; TC, total cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; CRP, C-reactive protein; UA, uric acid.